热门资讯> 正文

瑞思迈宣布CFO继任

2026-05-01 04:25

Resmed (RMD) chief financial officer Brett Sandercock will retire effective May 4, 2026.
Aaron Bloomer has been appointed CFO following a comprehensive search.
Bloomer joins from Exact Sciences, recently acquired by Abbott, where he served as CFO.
Sandercock will remain as an advisor to the CEO through the end of 2027.

More on ResMed

ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating
ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
ResMed Inc. 2026 Q2 - Results - Earnings Call Presentation
ResMed Q3 2026 Earnings Preview
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。